Cite
Critical appraisal of the use of regorafenib in the management of colorectal cancer
MLA
Festino L, et al. “Critical Appraisal of the Use of Regorafenib in the Management of Colorectal Cancer.” Cancer Management and Research, vol. 2013, no. default, Apr. 2013, pp. 49–55. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.32a2f4a84d324b519779aba63830dc95&authtype=sso&custid=ns315887.
APA
Festino L, Fabozzi A, Manzo A, Gambardella V, Martinelli E, Troiani T, De Vita F, Orditura M, Ciardiello F, & Morgillo F. (2013). Critical appraisal of the use of regorafenib in the management of colorectal cancer. Cancer Management and Research, 2013(default), 49–55.
Chicago
Festino L, Fabozzi A, Manzo A, Gambardella V, Martinelli E, Troiani T, De Vita F, Orditura M, Ciardiello F, and Morgillo F. 2013. “Critical Appraisal of the Use of Regorafenib in the Management of Colorectal Cancer.” Cancer Management and Research 2013 (default): 49–55. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.32a2f4a84d324b519779aba63830dc95&authtype=sso&custid=ns315887.